taurolidine has been researched along with Neoplasms, Pleural in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arni, S; Hillinger, S; Lardinois, D; Odermatt, B; Opitz, I; Rousson, V; Vogt, P; Weder, W | 1 |
| Hillinger, S; Hopkins-Donaldson, S; Lardinois, D; Opitz, I; Sigrist, B; Stahel, R; Weder, W | 1 |
2 other study(ies) available for taurolidine and Neoplasms, Pleural
| Article | Year |
|---|---|
Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment.
Topics: Animals; Anti-Infective Agents, Local; Antineoplastic Agents; Cell Line, Tumor; Chemokine CCL19; Chemokines, CC; Cisplatin; Combined Modality Therapy; Disease Models, Animal; Fibrin Tissue Adhesive; Male; Mesothelioma; Neoplasm Recurrence, Local; Pleural Neoplasms; Pneumonectomy; Povidone-Iodine; Rats; Rats, Inbred F344; Taurine; Thiadiazines | 2007 |
Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma.
Topics: Anti-Infective Agents, Local; Antineoplastic Agents; Biopsy; Blotting, Western; Caspase 3; Cell Death; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Cell Survival; Cisplatin; Drug Therapy, Combination; Enzyme Activation; Flow Cytometry; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Mesothelioma; Mitochondrial Membranes; Pleural Neoplasms; Povidone-Iodine; Reactive Oxygen Species; Taurine; Thiadiazines | 2007 |